Advertisement
Advertisement
U.S. Markets close in 6 hrs 29 mins
Advertisement
Advertisement
Advertisement
Advertisement

Century Therapeutics, Inc. (IPSC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.68+0.19 (+1.15%)
As of 09:30AM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close16.49
Open19.25
Bid2.69 x 900
Ask19.88 x 1200
Day's Range16.68 - 16.68
52 Week Range16.29 - 32.90
Volume1,121
Avg. Volume126,991
Market Cap914.474M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-3.29
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est36.25
  • GlobeNewswire

    Century Therapeutics to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

    PHILADELPHIA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that members of the senior management team have participated in a fireside chat in advance of the Piper Sandler 33rd Annual Virtual Healthcare Conference, being held November 30- December 2, 2021. A recording of the fireside chat will be available today at 10:00 AM ET on

  • GlobeNewswire

    Century Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates

    Lead program, CNTY-101 in relapsed/refractory non-Hodgkin’s lymphoma, remains on track for IND filing in mid-2022 Pre-clinical data from CNTY-101 program and CAR-iT platform to be presented at the ASH Annual Meeting Research and development update to be held on Thursday, December 16, 8:00-9:30 AM EST Made significant investment in building in-house manufacturing facility and new laboratory space Ended third quarter with cash, cash equivalents, and marketable securities of $400.3M PHILADELPHIA, N

  • GlobeNewswire

    Century Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Host Virtual Research & Development Update

    PHILADELPHIA, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that preclinical data from the Company’s CNTY-101 program and CAR-iT platform will be presented in two posters at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition, on December 11-14, 2021 in Atlanta, Georgia and virtually. The Company also announc

Advertisement
Advertisement